Claudia A. Salinas, Ph.D.
Affiliations: | 2009 | University of Washington, Seattle, Seattle, WA |
Area:
Epidemiology, Genetics, OncologyGoogle:
"Claudia Salinas"Parents
Sign in to add mentor| Janet Stanford | grad student | 2009 | University of Washington | |
| (Prostate cancer risk and inflammation: Association with aspirin and other NSAID use & selected inflammation pathway-related gene polymorphisms.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Salinas CA, Tsodikov A, Ishak-Howard M, et al. (2014) Prostate cancer in young men: an important clinical entity. Nature Reviews. Urology. 11: 317-23 |
| Zuhlke KA, Johnson AM, Okoth LA, et al. (2012) Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer. Familial Cancer. 11: 595-600 |
| Lange EM, Salinas CA, Zuhlke KA, et al. (2012) Early onset prostate cancer has a significant genetic component. The Prostate. 72: 147-56 |
| Kwon EM, Salinas CA, Kolb S, et al. (2011) Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 923-33 |
| Salinas CA, Kwon EM, FitzGerald LM, et al. (2010) Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. American Journal of Epidemiology. 172: 578-90 |
| Agalliu I, Kwon EM, Salinas CA, et al. (2010) Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes & Control : Ccc. 21: 289-300 |
| Cooney KA, Salinas CA, Ray AM, et al. (2010) Evaluation of the genetic component of early-onset prostate cancer. Journal of Clinical Oncology. 28: 4502-4502 |
| Wright JL, Salinas CA, Lin DW, et al. (2009) Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. The Journal of Urology. 182: 2702-7 |
| Fitzgerald LM, Kwon EM, Koopmeiners JS, et al. (2009) Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3231-7 |
| Penney KL, Salinas CA, Pomerantz M, et al. (2009) Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3223-30 |